Profilo
Mark G.
Eller worked as a Scientist at The Upjohn Co. He then worked as a Vice President-Clinical Pharmacology at Quintiles, Inc. (California) from 2001 to 2005.
After that, he worked as a SVP-Research & Clinical Development at Hoechst Marion Roussel, Inc. and as a Senior VP-Research & Clinical Development at Jazz Pharmaceuticals Plc.
Eller received his undergraduate and doctorate degrees from the University of Iowa.
Precedenti posizioni note di Mark G. Eller
| Società | Posizione | Fine |
|---|---|---|
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Direttore Tecnico/Scientifico/R&S | - |
The Upjohn Co.
The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Direttore Tecnico/Scientifico/R&S | - |
Hoechst Marion Roussel, Inc.
Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Direttore Tecnico/Scientifico/R&S | - |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | - |
Formazione di Mark G. Eller
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
The Upjohn Co.
The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoechst Marion Roussel, Inc.
Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
















